Platelet function analysis: at the edge of meaning

Thromb Haemost. 2009 Feb;101(2):217-9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenosine Diphosphate
  • Angioplasty, Balloon, Coronary / adverse effects
  • Angioplasty, Balloon, Coronary / instrumentation
  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Cell Adhesion Molecules / blood
  • Clopidogrel
  • Drug Resistance
  • Humans
  • Microfilament Proteins / blood
  • Patient Selection
  • Phosphoproteins / blood
  • Phosphorylation
  • Platelet Activation / drug effects*
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Function Tests* / standards
  • Predictive Value of Tests
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2 / blood
  • Receptors, Purinergic P2Y12
  • Reproducibility of Results
  • Stents
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Cell Adhesion Molecules
  • Microfilament Proteins
  • P2RY12 protein, human
  • Phosphoproteins
  • Platelet Aggregation Inhibitors
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y12
  • vasodilator-stimulated phosphoprotein
  • Adenosine Diphosphate
  • Clopidogrel
  • Ticlopidine
  • Aspirin